Non-neoplastic digestive system diseases

Disease

1 paper6 findings

  • Humans1

Associations

6

Recovery from pre-frail to robust

downin humans1HR 0.73

1 study
  1. Recovery from pre-frail to robust is associated with non-neoplastic digestive system diseases in humans (HR 0.73, 95% CI 0.57–0.94).

    “Recovery from pre-frail to robust (HR: 0.73, 95 % CI: 0.57-0.94) was associated with reduced NNDSD risk”

    Humans41% womensn = 5,299

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Progression from pre-frail to frail

upin humans1HR 1.39

1 study
  1. Progression from pre-frail to frail is associated with non-neoplastic digestive system diseases in humans (HR 1.39, 95% CI 1.08–1.81).

    “Progression from pre-frail to frail (HR: 1.39 95 % CI: 1.08-1.81) elevated the risk of NNDSD onset.”

    Humans41% womensn = 5,299

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Progression from robust to frail

upin humans1HR 2.91

1 study
  1. Progression from robust to frail is associated with non-neoplastic digestive system diseases in humans (HR 2.91, 95% CI 1.72–4.90).

    “frail (HR: 2.91, 95 % CI: 1.72-4.90) was associated with NNDSD risk relative to participants who remained robust.”

    HumansCompared with remaining robust41% womensn = 5,299

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Progression from robust to pre-frail

upin humans1HR 1.64

1 study
  1. Progression from robust to pre-frail is associated with non-neoplastic digestive system diseases in humans (HR 1.64, 95% CI 1.30–2.10).

    “Progression to pre-frail (HR: 1.64, 95 % CI: 1.30-2.10)”

    HumansCompared with remaining robust41% womensn = 5,299

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Frailty

upin humans1HR 2.39

1 study
  1. Frailty is associated with non-neoplastic digestive system diseases in humans (HR 2.39, 95% CI 1.99–2.89).

    “frail (HR: 2.39, 95 % CI: 1.99-2.89) exhibited elevated NNDSD incidence.”

    HumansBaseline frail status41% womensn = 6,994

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Pre-frailty

upin humans1HR 1.55

1 study
  1. Pre-frailty is associated with non-neoplastic digestive system diseases in humans (HR 1.55, 95% CI 1.38–1.75).

    “Participants classified as pre-frail (hazard ratio [HR]: 1.55, 95 % confidence interval [CI]: 1.38-1.75)”

    HumansBaseline pre-frail status41% womensn = 6,994

    Associations between changes in frailty status and non-neoplastic digestive system diseases: A cohort study based on the China health and retirement longitudinal study

    Experimental gerontology16 Aug 2025

Latest